Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)	6 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2020
Cash Flows from Operating Activities:
Net (loss) income	$ 1,306,153	$ (1,874,080)
Change in fair value of warrant liability	(1,224,597)	1,975,156
Offering costs allocated to warrant liability	19,946
Interest earned on marketable securities held in Trust Account	(295,788)	(787,350)
Unrealized gain on marketable securities held in Trust Account	(227)	(2,056)
Deferred tax provision	48	384
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(176,859)	77,134
Accrued expenses	126,891	20,939
Income taxes payable	26,934	(21,051)
Net cash used in operating activities	(217,499)	(610,924)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(130,015,520)
Cash withdrawn from Trust Account for franchise and income tax payments		419,894
Net cash provided by (used in) investing activities	(130,015,520)	419,894
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	127,415,209
Proceeds from sale of Private Warrants	3,950,311	41,458
Advances from related party	203,958
Repayment of advances from related party	(187,500)
Proceeds from promissory note – related party	100,569
Repayment of promissory note – related party	(100,230)
Payment of offering costs	(786,728)
Net cash provided by financing activities	130,595,589
Net Change in Cash	362,570	(191,030)
Cash – Beginning of period		362,570
Cash – End of period	362,570	171,540
Supplementary cash flow information:
Cash paid for income taxes		47,779
Non-Cash investing and financing activities:
Initial classification of common stock subject to possible redemption (Restated – see Note 2)	130,015,520
Accretion change in value of common stock subject to possible redemption (Restated – see Note 2)	181,842	$ 347,597
Issuance of Representative Shares	910
Offering cost paid directly by stockholder in consideration for the issuance of common stock	$ 25,000